Competitive intelligence is often broad in scope. However, for life sciences teams, the challenge is not access to information, but how to interpret it and use it to support decisions.
Competitor activity, clinical developments, and regulatory changes generate a constant flow of signals. Without a clear way to structure these inputs, it can be difficult to understand what matters and what to act on. Therefore, a more structured approach helps bring clarity.
At m360 Research, competitive intelligence is organised across three core areas. Each plays a distinct role in helping teams build a clearer and more actionable view of the competitive landscape.
1. Monitoring and Competitive Insights
- Continuous competitor tracking: Ongoing monitoring across multiple sources keeps teams aware of changes in strategy, positioning, and pipeline development.
- Clinical trial intelligence: Tracking trial progress, results, and design offers insight into competitor priorities and potential future developments.
- Regulatory and approval tracking: Approvals, submissions, and regulatory updates bring greater clarity to timelines and expected market entry.
- Commercial and launch monitoring: Observing launches, positioning, and promotional activity reveals how competitors are approaching the market in practice.
- Conference coverage: Insights from key industry events often signal emerging data, shifts in messaging, and evolving strategic direction.
2. Decision-Driven Strategic Support
Monitoring alone does not provide enough direction. This area focuses on interpreting developments and translating them into clear implications for the business.
- Portfolio and pipeline strategy: Competitor activity informs decisions around portfolio priorities and future investment.
- Scenario planning and war gaming: Exploring potential developments and responses allows pharma and biotech teams to prepare for different outcomes.
- Strategy workshops: Structured sessions bring stakeholders together and turn insight into aligned action.
- Go-to-market and lifecycle management strategy: Launch planning, positioning, and ongoing strategy benefit from a clearer view of the competitive environment.
- Indication prioritisation: Evaluating opportunities in the context of competitive intensity helps guide focus and resource allocation.
- Commercial benchmarking: Comparing positioning, performance, and strategy highlights strengths and identifies gaps.
3. Therapy Area Deep Dives and Ad Hoc Intelligence
- Therapy area landscape analysis: Mapping the competitive environment within a disease area builds a clearer picture of key players, trends, and gaps.
- Key opinion leader identification and profiling: Understanding influential experts and their perspectives supports engagement and strategic planning.
- Scientific literature reviews: Published research highlights emerging evidence and signals shifts in the landscape.
- Business development and licensing support: Insight into competitors and assets strengthens partnership, acquisition, and licensing decisions.
- Custom competitive intelligence dashboards: Tailored tools allow teams to track and interpret relevant data in a structured way.
- Social media intelligence: Digital channels offer a view into real-world perspectives from healthcare professionals and patients.
Conclusion
If you are exploring a competitive intelligence project, you can send an RFP to info@m360research.com to discuss your requirements.


